Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

December 12, 2022

Study Completion Date

June 6, 2023

Conditions

Covid19

Interventions

DRUG

NTR-441

DRUG

Placebo

Trial Locations (4)

Klinik Favoriten, Vienna

Medical University Vienna, Department of Clinical Pharmacology, Vienna

Kyiv City Clinical Hospital#1, Kyiv

Vinnytsa City Clinical Hospital # 1, Vinnytsia